Retatrutide, Multi Agonist Obesity Drugs, and the PBM Access War

On The Pen GLP-1 News

# Full Transcript

**Podcast:** On The Pen GLP-1 News

## Transcript

[SPEAKER_A] What happens when the next generation of obesity medications that we're gonna talk about today collides with one of the most distrusted parts of the American healthcare system? This week, that's what we're diving into. We're diving deep into the future of Multi Agonist Obesity Therapies like retatrutide, retatrutide, other oral triple agonist amylin combinations, IGF-1 combinations, and some absolutely wild pipeline drugs that I'm gonna guarantee most of you have never heard of. But at the exact same time that this is all happening, we've got Tennessee, the state of Tennessee, signing into law landmark PBM legislation that will make a huge impact and hopefully send ripple effects throughout the United States. And questions around retatrutide pricing, biologic status, all of this is heating up, and the battle over who controls access to these therapies is getting louder and louder. Obesity medicine is no longer just on the edge of healthcare policy. It's actually beginning to reshape healthcare policy. Welcome back to On the Pen. Welcome to the On the Pen podcast with your host, Dave Knapp. Welcome back to this On the Pen podcast. I'm your host, Dave Knapp, man on the Mounjaro. That's why I'm here. You are on the pen. Wegovy, Saxenda, Victoza, Trulicity, Mounjaro, Zepbound, Compound, That Pen. It's what we talk about each and every week here on this podcast as we bring you information that empowers you to have more competent and confident conversations with your medical providing team. So if that sounds helpful for you and you're watching on YouTube, hit the subscribe button down below. Also hit the hype button. Because that helps to push this content out to the millions of people who still need to seek care for their obesity that don't know that this stuff is even out there, right? And so we exist to help all of you have better conversations with your doctor. So share it with somebody by hitting the Hype button down below. I also wanna shout out our friends at Shed because we could not do this podcast without our friends at Shed. Visit tryshed.com, use code OTP25. That's gonna save you 25% off of their obesity therapies. Listen, if you felt flat out shut out every time you go to the doctor, and it's just everything's about your weight but no tools to actually fight the chronic disease. And maybe worse off, your doctor doesn't even recognize that obesity is a chronic, relapsing, and multifactorial disease. The experts at S.H.E.D. will help you connect with licensed medical professionals who can help you navigate that. Check out trished.com. Use code OTP25, save 25% off obesity care today. And thank them for sponsoring the On the Pen podcast. We're so grateful to them each and every week. Now I want to start this week with a story, just more of a story. This isn't a news story, but it's something that kind of came across my feed this past week that I think captures wh...

Retatrutide, Multi Agonist Obesity Drugs, and the PBM Access War

Transcript

Built for investment professionals

Every day you wait, your competitors are finding
edge in conversations you're not hearing.

Retatrutide, Multi Agonist Obesity Drugs, and the PBM Access War

Transcript

Built for investment professionals

Every day you wait, your competitors are findingedge in conversations you're not hearing.

Every day you wait, your competitors are finding
edge in conversations you're not hearing.